José L. McFaline-Figueroa's Avatar

José L. McFaline-Figueroa

@jlmcfalinefigueroa

Assistant Professor, BME, Columbia University

86
Followers
262
Following
4
Posts
13.11.2024
Joined
Posts Following

Latest posts by José L. McFaline-Figueroa @jlmcfalinefigueroa

IICD Newsletter October 2025

IICD Newsletter October 2025

October newsletter is out. Watch the latest Faces of IICD interview, read about the latest breast cancer research highlights and the GROW conference, and more.

cancerdynamics.columbia.edu/news/iicd-ne...

#BreastCancerAwareness @nygenome.org @elhamazizi.bsky.social @jlmcfalinefigueroa.bsky.social

06.10.2025 13:17 👍 2 🔁 1 💬 0 📌 0
Apply - Interfolio {{$ctrl.$state.data.pageTitle}} - Apply - Interfolio

We’re hiring!📣

Exciting opportunity at the Irving Institute for Cancer Dynamics and School of Engineering and Applied Science at Columbia: Associate Research Scientist. Lead pooled CRISPR + Perturb-seq screens to close AI-identified knowledge gaps. Apply apply.interfolio.com/172825

29.09.2025 22:32 👍 2 🔁 1 💬 0 📌 0

Please reach out if you have questions!

16.09.2025 15:02 👍 0 🔁 0 💬 0 📌 0
Apply - Interfolio {{$ctrl.$state.data.pageTitle}} - Apply - Interfolio

Please share!

The Irving Institute for Cancer Dynamics and the Fu Foundation School of Engineering & Applied Science at Columbia are seeking an Associate Research Scientist to design & execute pooled CRISPR and Perturb-seq screens. Apply here: apply.interfolio.com/172825

16.09.2025 15:02 👍 3 🔁 1 💬 1 📌 1
Preview
Group Leader - Genome Biology Unit Are you ready to lead groundbreaking research in Genome Biology? Join us at EMBL! We are seeking a motivated scientist to lead an independent research group addressing exciting and original biological...

To all post-docs: The Genome Biology dept ‪@embl.org
has an Independent faculty position. Fantastic place to set up your lab –great package: core funding, fantastic Ph.D. students, cutting edge core facilities & great colleagues. Closing date Sept 19th
embl.wd103.myworkdayjobs.com/en-US/EMBL/j...

30.07.2025 13:41 👍 192 🔁 225 💬 0 📌 9

Wondeful collaboration! This study with the Shah lab (Columbia Chemistry), led by Anne Vlimmeren and Ross Giglio, profiled disease associated SHP2 variants, linking variant-specific changes in molecular programs with differences in structure and substrate specificity. Check it out!

10.07.2025 16:51 👍 5 🔁 1 💬 0 📌 0
Post image

It’s been a tough few weeks. My 10yo daughter was diagnosed with a very rare, aggressive cancer called interdigitating dendritic cell sarcoma (IDCS). I’m reaching out to identify clinicians/patients who have encountered pediatric IDCS or other (non-LCH) dendritic or histiocytic sarcomas cases.

08.02.2025 21:21 👍 1009 🔁 848 💬 83 📌 32
Preview
In Early-Phase Pancreatic Cancer Clinical Trial, Investigational mRNA Vaccine Induces Sustained Immune Activity in Small Patient Group Learn how MSK researchers are deploying mRNA vaccines against pancreatic cancer.

I wonder if spreading extremely encouraging experimental results on helping treat pancreatic cancer with *gasp* mRNA vaccines may help people who have villainized them come around. This is a good press release on the study and links to the Nature paper. www.mskcc.org/news/can-mrn...

28.02.2025 17:02 👍 1486 🔁 314 💬 36 📌 11
Preview
NIH ban on renewing senior scientists adds to assaults on its in-house research Policy follows firings of tenure-track scientists and suspension of training programs

Of the 4000 researchers at NIH, only 20% are tenured. They’re going to fire all the rest as their contracts come up for renewal, absolutely decimating research at the NIH. This is catastrophic, not just for Americans, but for the whole world.

www.science.org/content/arti...

28.02.2025 06:19 👍 7261 🔁 2671 💬 241 📌 154